Gabapentin Capsule
Product Images NDC 58118-1102

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 58118-1102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

A formula illustrating the calculation of creatinine clearance (CLCr), showing the relationship between age, weight, and serum creatinine. The formula includes an adjustment factor for female patients.*

FDA Label Image

Chem Structure (Gabapentin Capsules Usp 2)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to an amino group and an acetic acid moiety.*

FDA Label Image

10 (Gabapentin Capsules Usp 3)

A line graph comparing mean pain scores over 8 weeks between placebo and gabapentin 3600 mg/day groups during a 4-week dose titration period followed by a 4-week fixed dose period. Pain scores decrease over time with gabapentin, while placebo scores remain relatively stable.*

FDA Label Image

10 (Gabapentin Capsules Usp 4)

A line graph depicting mean pain scores over 7 weeks for placebo and two gabapentin dose groups (1800 mg/day and 2400 mg/day). The x-axis represents weeks, starting at baseline, and the y-axis shows the mean pain score. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, showing that pain scores decrease more in gabapentin groups compared to placebo over time.*

FDA Label Image

10 (Gabapentin Capsules Usp 5)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares two studies, each with placebo (PBO) and gabapentin (GBP) treatment groups at different dosages. The y-axis shows percentage responders from 0% to 100%. Study 1 compares PBO and GBP 3600 mg, while Study 2 compares PBO, GBP 1800 mg, and GBP 2400 mg. Significant differences are indicated by asterisks.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

A scatter plot showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin. The graph compares results from three studies labeled as Study a, Study b, and Study c, with data points plotted at daily doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Gabapentin 100mg Capsules 30ct Blister Cards (Gabapentin Capsules Usp 7)

Gabapentin 100 mg capsules packaging label from Clinical Solutions Wholesale, LLC. It shows a quantity of 30 capsules with NDC 58118-2101-8. The label includes manufacturer details: Amneal Pharmaceuticals of Bridgewater, NJ, USA, with manufacturing NDC 65162-0101-50 and lot number SAMPLE123. Expiration date is April 2025.*

FDA Label Image

Gabapentin 300mg Capsules 30ct Blister Cards (Gabapentin Capsules Usp 8)

Gabapentin 300 mg capsules packaging label from Clinical Solutions Wholesale. The label includes NDC 58118-1102-8 with a quantity of 30 capsules. Manufacturer is Amed Pharmaceuticals of Bridgewater, NJ. Also shows repack and distribution information by Clinical Solutions Wholesale, LLC, Franklin, TN.*

FDA Label Image

Gabapentin 400mg Capsules 30ct Blister Cards (Gabapentin Capsules Usp 9)

Label for Gabapentin 400 mg capsules from Clinical Solutions Wholesale. The label includes the NDC number 58118-1103-8, a quantity of 30 capsules, manufacturing details by Amed Pharmaceuticals of Bridgewater, NJ, and repackaging information from Clinical Solutions Wholesale, Franklin, TN. Additional batch and serial number placeholders are present, along with a QR code and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.